China Isotope & Radiation Corp
HKEX:1763
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
3.5B HKD | 4.9 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 31.4 | ||
CH |
Alcon AG
SIX:ALC
|
35.7B CHF | 28.1 | ||
DK |
Coloplast A/S
CSE:COLO B
|
193.7B DKK | 35.1 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 29.5 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 31.6 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.2T KRW | -127.3 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.8B CNY | 40 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 18 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.4B USD | 16.9 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | -305.3 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.